Aflac EVP, CFO Aflac Japan Sells 5,492 Company Shares
Aflac executive Steven K. Beaver, EVP and CFO of Aflac Japan, reported selling 5,492 shares of Aflac Inc. common stock on 12/12/2025 at a weighted average price of $109.5266 per share, through multiple trades between $109.50 and $109.575.
Rhea-AI Filing Summary
Aflac executive Steven K. Beaver, EVP and CFO of Aflac Japan, reported selling 5,492 shares of Aflac Inc. common stock on 12/12/2025 at a weighted average price of $109.5266 per share, through multiple trades between $109.50 and $109.575. After this transaction, he beneficially owns 38,368 shares of Aflac common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,492 | $109.5266 | $602K |
Footnotes (1)
- F1. The price is the weighted average sale price of the aggregate number of shares that were sold. These shares were sold in multiple transactions at prices ranging from $109.50 to $109.575. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider stock transaction did Aflac (AFL) report for Steven K. Beaver?
The filing reports that Steven K. Beaver, EVP and CFO of Aflac Japan, sold 5,492 shares of Aflac Inc. common stock on 12/12/2025.
What is Steven K. Beaver's role at Aflac (AFL)?
Steven K. Beaver is identified as an officer of Aflac, serving as EVP, CFO Aflac Japan.
On what date did Steven K. Beaver's Aflac (AFL) stock sale occur?
The reported transaction date for the common stock sale is 12/12/2025.
Does this report show any derivative securities for Aflac (AFL)?
The section for derivative securities does not list any acquired, disposed of, or beneficially owned derivative securities in this report.
AI-generated analysis. How Rhea-AI works. Not financial advice.